Drug Stocks on Sale and J&J Spin-Offs

Jim outlines opportunities in drug stocks, calling Johnson & Johnson a strong entry after its spin-off moves.

Play episode from 08:54

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!